OFT conclusions on UK medicines distribution

Office of Fair Trading report (100 pages, PDF) on the distribution of medicines in the UK. This was partly prompted by plans from Pfizer and AstraZeneca to take greater control of the distribution chain for their products.

Both recommendations in the report are addressed to the Government in its role as funder of the NHS. They relate to:

The report does not appear to address any competition law issues.

For further information or advice please contact Franck Latrémolière.

Filed under Healthcare, OFT, Pharmaceuticals.

Reckon LLP is an economics consultancy with expertise in data analysis, economic regulation and competition law.

About Reckon